The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Nanomedicine is the medical application of nanotechnology.Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines.
The global Nanomedicine market was valued at US$ 155.5 million in 2023 and is anticipated to reach US$ 246.8 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
Nanomedicine refers to the application of nanotechnology in the field of medicine. It involves the use of nanoparticles, nanomaterials, and nanodevices to deliver drugs, diagnose diseases, and monitor the health of patients at the molecular level.
Nanoparticles and nanomaterials can be engineered to have specific properties, such as size, shape, and surface chemistry, which allow for targeted and controlled delivery of drugs to specific cells or tissues in the body. This targeted drug delivery system increases the efficiency and effectiveness of treatments while minimizing side effects.
In addition to drug delivery, nanomedicine also includes the development of nanosensors and nanodevices for diagnostic purposes. These tiny devices can detect molecular markers of diseases, such as proteins or genetic material, at an early stage, enabling early intervention and personalized medicine. Nanosensors can also be used to monitor the health of patients in real-time, providing continuous data on various health parameters.
Nanomedicine has the potential to revolutionize healthcare by providing more precise and personalized treatments. It has the potential to improve drug efficacy, reduce drug toxicity, and enhance patient outcomes. However, there are still challenges that need to be addressed, such as the safety and toxicity of nanoparticles, as well as regulatory approval processes for nano-based medical products.
This report aims to provide a comprehensive presentation of the global market for Nanomedicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanomedicine.
Report Scope
The Nanomedicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nanomedicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nanomedicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Combimatrix
- Ablynx
- Abraxis Bioscience
- Celgene
- Mallinckrodt
- Arrowhead Research
- GE Healthcare
- Merck
- Pfizer
- Nanosphere
- Epeius Biotechnologies
- Cytimmune Sciences
- Nanospectra Biosciences
Segment by Type
- Quantum dots
- Nanoparticles
- Nanoshells
- Nanotubes
- Nanodevices
Segment by Application
- oncology
- Infectious diseases
- Cardiology
- Orthopedics
- Others
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nanomedicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanomedicine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Quantum dots
1.2.3 Nanoparticles
1.2.4 Nanoshells
1.2.5 Nanotubes
1.2.6 Nanodevices
1.3 Market by Application
1.3.1 Global Nanomedicine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 oncology
1.3.3 Infectious diseases
1.3.4 Cardiology
1.3.5 Orthopedics
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nanomedicine Market Perspective (2019-2030)
2.2 Nanomedicine Growth Trends by Region
2.2.1 Global Nanomedicine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nanomedicine Historic Market Size by Region (2019-2024)
2.2.3 Nanomedicine Forecasted Market Size by Region (2025-2030)
2.3 Nanomedicine Market Dynamics
2.3.1 Nanomedicine Industry Trends
2.3.2 Nanomedicine Market Drivers
2.3.3 Nanomedicine Market Challenges
2.3.4 Nanomedicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nanomedicine Players by Revenue
3.1.1 Global Top Nanomedicine Players by Revenue (2019-2024)
3.1.2 Global Nanomedicine Revenue Market Share by Players (2019-2024)
3.2 Global Nanomedicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nanomedicine Revenue
3.4 Global Nanomedicine Market Concentration Ratio
3.4.1 Global Nanomedicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanomedicine Revenue in 2023
3.5 Nanomedicine Key Players Head office and Area Served
3.6 Key Players Nanomedicine Product Solution and Service
3.7 Date of Enter into Nanomedicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanomedicine Breakdown Data by Type
4.1 Global Nanomedicine Historic Market Size by Type (2019-2024)
4.2 Global Nanomedicine Forecasted Market Size by Type (2025-2030)
5 Nanomedicine Breakdown Data by Application
5.1 Global Nanomedicine Historic Market Size by Application (2019-2024)
5.2 Global Nanomedicine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Nanomedicine Market Size (2019-2030)
6.2 North America Nanomedicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nanomedicine Market Size by Country (2019-2024)
6.4 North America Nanomedicine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nanomedicine Market Size (2019-2030)
7.2 Europe Nanomedicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nanomedicine Market Size by Country (2019-2024)
7.4 Europe Nanomedicine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nanomedicine Market Size (2019-2030)
8.2 Asia-Pacific Nanomedicine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nanomedicine Market Size by Region (2019-2024)
8.4 Asia-Pacific Nanomedicine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nanomedicine Market Size (2019-2030)
9.2 Latin America Nanomedicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nanomedicine Market Size by Country (2019-2024)
9.4 Latin America Nanomedicine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nanomedicine Market Size (2019-2030)
10.2 Middle East & Africa Nanomedicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nanomedicine Market Size by Country (2019-2024)
10.4 Middle East & Africa Nanomedicine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Combimatrix
11.1.1 Combimatrix Company Detail
11.1.2 Combimatrix Business Overview
11.1.3 Combimatrix Nanomedicine Introduction
11.1.4 Combimatrix Revenue in Nanomedicine Business (2019-2024)
11.1.5 Combimatrix Recent Development
11.2 Ablynx
11.2.1 Ablynx Company Detail
11.2.2 Ablynx Business Overview
11.2.3 Ablynx Nanomedicine Introduction
11.2.4 Ablynx Revenue in Nanomedicine Business (2019-2024)
11.2.5 Ablynx Recent Development
11.3 Abraxis Bioscience
11.3.1 Abraxis Bioscience Company Detail
11.3.2 Abraxis Bioscience Business Overview
11.3.3 Abraxis Bioscience Nanomedicine Introduction
11.3.4 Abraxis Bioscience Revenue in Nanomedicine Business (2019-2024)
11.3.5 Abraxis Bioscience Recent Development
11.4 Celgene
11.4.1 Celgene Company Detail
11.4.2 Celgene Business Overview
11.4.3 Celgene Nanomedicine Introduction
11.4.4 Celgene Revenue in Nanomedicine Business (2019-2024)
11.4.5 Celgene Recent Development
11.5 Mallinckrodt
11.5.1 Mallinckrodt Company Detail
11.5.2 Mallinckrodt Business Overview
11.5.3 Mallinckrodt Nanomedicine Introduction
11.5.4 Mallinckrodt Revenue in Nanomedicine Business (2019-2024)
11.5.5 Mallinckrodt Recent Development
11.6 Arrowhead Research
11.6.1 Arrowhead Research Company Detail
11.6.2 Arrowhead Research Business Overview
11.6.3 Arrowhead Research Nanomedicine Introduction
11.6.4 Arrowhead Research Revenue in Nanomedicine Business (2019-2024)
11.6.5 Arrowhead Research Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Company Detail
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Nanomedicine Introduction
11.7.4 GE Healthcare Revenue in Nanomedicine Business (2019-2024)
11.7.5 GE Healthcare Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Nanomedicine Introduction
11.8.4 Merck Revenue in Nanomedicine Business (2019-2024)
11.8.5 Merck Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Nanomedicine Introduction
11.9.4 Pfizer Revenue in Nanomedicine Business (2019-2024)
11.9.5 Pfizer Recent Development
11.10 Nanosphere
11.10.1 Nanosphere Company Detail
11.10.2 Nanosphere Business Overview
11.10.3 Nanosphere Nanomedicine Introduction
11.10.4 Nanosphere Revenue in Nanomedicine Business (2019-2024)
11.10.5 Nanosphere Recent Development
11.11 Epeius Biotechnologies
11.11.1 Epeius Biotechnologies Company Detail
11.11.2 Epeius Biotechnologies Business Overview
11.11.3 Epeius Biotechnologies Nanomedicine Introduction
11.11.4 Epeius Biotechnologies Revenue in Nanomedicine Business (2019-2024)
11.11.5 Epeius Biotechnologies Recent Development
11.12 Cytimmune Sciences
11.12.1 Cytimmune Sciences Company Detail
11.12.2 Cytimmune Sciences Business Overview
11.12.3 Cytimmune Sciences Nanomedicine Introduction
11.12.4 Cytimmune Sciences Revenue in Nanomedicine Business (2019-2024)
11.12.5 Cytimmune Sciences Recent Development
11.13 Nanospectra Biosciences
11.13.1 Nanospectra Biosciences Company Detail
11.13.2 Nanospectra Biosciences Business Overview
11.13.3 Nanospectra Biosciences Nanomedicine Introduction
11.13.4 Nanospectra Biosciences Revenue in Nanomedicine Business (2019-2024)
11.13.5 Nanospectra Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
